ConductScience.org, home

Paper40869293

Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies.

Ziemian M and 10 others. Int J Mol Sci, 2025. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies. Papers, record 40869293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40869293

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integrative Approaches to Myopathies and Muscular Dystrophies: Molecular Mechanisms, Diagnostics, and Future Therapies.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.05, provisional
iCite
Revised in PubMed
2025-08-31
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ziemian MMaja
2Szmydtka JJoanna
3Snoch WWojciech
4Milner SSandrahttps://orcid.org/0009-0007-1667-5140
5Wojciechowski SSzymon
6Dłuszczakowska AAleksandra
7Chojnowski JWJakub W
8Pallach ZZofiahttps://orcid.org/0009-0002-2634-4971
9Żamojda KKatarzynahttps://orcid.org/0009-0001-2215-3169
10Węgrzyn GGrzegorzhttps://orcid.org/0000-0003-4042-7466
11Rintz EEsterahttps://orcid.org/0000-0003-4941-766X

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Muscular DystrophiesMajor topic
Muscular DiseasesMajor topic
Humans
Genetic Therapy
Autophagy
Animals

Source PubMed

References311

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,979,809A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies.Biomedicines2023https://conductscience.org/library/papers/36979809PubMed
237,108,502Identification of Signature Genes of Dilated Cardiomyopathy Using Integrated Bioinformatics Analysis.Int J Mol Sci2023https://conductscience.org/library/papers/37108502PubMed
339,017,652Current advance on distal myopathy genetics.Curr Opin Neurol2024https://conductscience.org/library/papers/39017652PubMed
428,763,305Update on diagnostics of metabolic myopathies.Curr Opin Neurol2017https://conductscience.org/library/papers/28763305PubMed
519,258,857Metabolic myopathies: update 2009.J Clin Neuromuscul Dis2009https://conductscience.org/library/papers/19258857PubMed
634,645,707Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis.Neurology2021https://conductscience.org/library/papers/34645707PubMed
737,664,462Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata.Front Cell Dev Biol2023https://conductscience.org/library/papers/37664462PubMed
837,239,314Metabolic Myopathies in the Era of Next-Generation Sequencing.Genes (Basel)2023https://conductscience.org/library/papers/37239314PubMed
930,804,884Advances in Quantitative Imaging of Genetic and Acquired Myopathies: Clinical Applications and Perspectives.Front Neurol2019https://conductscience.org/library/papers/30804884PubMed
1026,160,630Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy.J Am Coll Cardiol2015https://conductscience.org/library/papers/26160630PubMed
1128,888,851Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa.Mol Genet Metab2017https://conductscience.org/library/papers/28888851PubMed
1228,251,827Muscle wasting in young patients with dilated cardiomyopathy.J Cachexia Sarcopenia Muscle2017https://conductscience.org/library/papers/28251827PubMed
1319,563,540Myofibrillar myopathies: a clinical and myopathological guide.Brain Pathol2009https://conductscience.org/library/papers/19563540PubMed
1433,511,244Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD.Mol Ther Methods Clin Dev2021https://conductscience.org/library/papers/33511244PubMed
1537,917,377Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review.BioDrugs2024https://conductscience.org/library/papers/37917377PubMed
1627,602,406The Clinical Outcome Study for dysferlinopathy: An international multicenter study.Neurol Genet2016https://conductscience.org/library/papers/27602406PubMed
1726,786,644A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.Can J Neurol Sci2016https://conductscience.org/library/papers/26786644PubMed
1829,894,794Two novel COL6A3 mutations disrupt extracellular matrix formation and lead to myopathy from Ullrich congenital muscular dystrophy and Bethlem myopathy spectrum.Gene2018https://conductscience.org/library/papers/29894794PubMed
1935,745,859Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective.Pharmaceutics2022https://conductscience.org/library/papers/35745859PubMed
2016,371,426Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts.FASEB J2006https://conductscience.org/library/papers/16371426PubMed

See all 311 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42,851,151Co-Occurrence of Facioscapulohumeral Muscular Dystrophy and Myasthenia Gravis: A Systematic Review and Meta-Analysis of Individual Patient Data.Eur J Neurol2026https://conductscience.org/library/papers/42851151PubMed
42,737,844Emerging Roles of Dystroglycan in Cardiac Remodeling, Fibrosis, and Heart Failure.Int J Mol Sci2026https://conductscience.org/library/papers/42737844PubMed
42,680,716Paraneoplastic Myopathy as a Possible Initial Presentation of Sporadic Burkitt Lymphoma in an Immunocompetent Adult: A Case Report.Cancer Rep (Hoboken)2026https://conductscience.org/library/papers/42680716PubMed
42,505,411Distal Myopathies and Beyond: An Updated Overview of the Welander Distal Myopathy.Cells2026https://conductscience.org/library/papers/42505411PubMed
42,157,960MicroRNA-based targeting strategies enable AAV-mediated, tissue-selective gene expression in adipose tissue and skeletal muscle of mice.Mol Ther Adv2026https://conductscience.org/library/papers/42157960PubMed
42,078,424Fibro-adipogenic progenitors enhance functional and structural properties of human 3D tissue engineered skeletal muscles.J Tissue Eng2026https://conductscience.org/library/papers/42078424PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40869293

GET https://conductscience.org/api/papers/v1/40869293/references?page=2